MiR-99a promotes proliferation targeting FGFR3 in human epithelial ovarian cancer cells

Biomedicine and Pharmacotherapy

Volumn 68, Issue 2, 2014, Pages 163-169

  Jiang, Haiyang ^a,b   Qu, Luyun ^b   Wang, Yan ^b   Cong, Jianglin ^b   Wang, Wenshuang ^b   Yang, Xingsheng ^a  

^a SHANDONG UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

EOC; MiR 99a; Ovarian cancer; Proliferation

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; MICRORNA; MICRORNA 99A; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER PROGNOSIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUCIFERASE ASSAY; OVARY CARCINOMA; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

EOC; FGFR(3); MIR-99A; OVARIAN CANCER; PROLIFERATION;

BASE SEQUENCE; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; HUMANS; LUCIFERASES, RENILLA; MICRORNAS; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; PLASMIDS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RNA, SMALL INTERFERING; TRANSFECTION; UP-REGULATION;

EID: 84897050856     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2013.12.001     Document Type: Article

References (34)

1. Kumaran G.C., Jayson G.C., Clamp A.R. Antiangiogenic drugs in ovarian cancer. Br J Cancer 2009, 100:1-7.
2. Williams T.I., Toups K.L., Saggese D.A., Kalli K.R., Cliby W.A., Muddiman D.C. Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers. J Proteome Res 2007, 6:2936-2962.
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
4. Lin J., Huang S., Wu S., et al. MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. Carcinogenesis 2011, 32:1641-1647.
5. Schommer C., Palatnik J.F., Aggarwal P., et al. Control of jasmonate biosynthesis and senescence by miR319 targets. PLoS Biol 2008, 6:e230.
6. Ghosh G., Subramanian I.V., Adhikari N., et al. Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis. J Clin Invest 2010, 120:4141-4154.
7. Lau P., Hudson L.D. MicroRNAs in neural cell differentiation. Brain Res 2010, 1338:14-19.
8. Jovanovic M., Hengartner M.O. miRNAs and apoptosis: RNAs to die for. Oncogene 2006, 25:6176-6187.
9. Liu B., Wu X., Liu B., et al. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta 2012, 1822:1692-1704.
10. Hu J.R., Lv G.H., Yin B.L. Altered microRNA expression in the ischemic-reperfusion spinal cord with atorvastatin therapy. J Pharmacol Sci 2013, 121:343-346.
11. Bhattacharya R., Nicoloso M., Arvizo R., et al. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res 2009, 69:9090-9095.
12. Creighton C.J., Fountain M.D., Yu Z., et al. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res 2010, 70:1906-1915.
13. Iorio M.V., Visone R., Di Leva G., et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007, 67:8699-8707.
14. Yang N., Kaur S., Volinia S., et al. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res 2008, 68:10307-10314.
15. Corney D.C., Hwang C.I., Matoso A., et al. Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res 2010, 16:1119-1128.
16. Peng D.X., Luo M., Qiu L.W., He Y.L., Wang X.F. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer. Oncol Rep 2012, 27:1238-1244.
17. Yin G., Chen R., Alvero A.B., et al. TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene 2010, 29:3545-3553.
18. Li D., Liu X., Lin L., et al. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem 2011, 286:36677-36685.
19. Sun D., Lee Y.S., Malhotra A., et al. miR-99 family of microRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. Cancer Res 2011, 71:1313-1324.
20. Chen Z., Jin Y., Yu D., et al. Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol 2012, 48:686-691.
21. Catto J.W., Miah S., Owen H.C., et al. Distinct microRNA alterations characterize high- and low-grade bladder cancer. Cancer Res 2009, 69:8472-8481.
22. Nam E.J., Yoon H., Kim S.W., et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 2008, 14:2690-2695.
23. Shimakami T., Yamane D., Welsch C., Hensley L., Jangra R.K., Lemon S.M. Base pairing between hepatitis C virus RNA and microRNA 122 3' of its seed sequence is essential for genome stabilization and production of infectious virus. J Virol 2012, 86:7372-7383.
24. Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198-201.
25. Cui L., Zhou H., Zhao H., et al. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma. BMC Cancer 2012, 12:546.
26. Kan C.W., Hahn M.A., Gard G.B., et al. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer. BMC Cancer 2011, 12:627.
27. Resnick K.E., Alder H., Hagan J.P., Richardson D.L., Croce C.M., Cohn D.E. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009, 112:55-59.
28. Lou Y., Yang X., Wang F., Cui Z., Huang Y. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int J Mol Med 2010, 26:819-827.
29. Yang H., Kong W., He L., et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 2008, 68:425-433.
30. 3 controls tumor growth induced by Src-related oncogenic pathways. Oncogene 2011, 30:3489-3501.
31. White N.M., Chow T.F., Mejia-Guerrero S., et al. Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer. Br J Cancer 2010, 102:1244-1253.
32. Nakano H., Yamada Y., Miyazawa T., Yoshida T. Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells. Int J Oncol 2013, 42:1875-1882.
33. Johnson S.M., Grosshans H., Shingara J., et al. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647.
34. Schultz J., Lorenz P., Gross G., Ibrahim S., Kunz M. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res 2008, 18:549-557.